A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease

NCT00002337 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Vesnarinone

Sponsor

Otsuka America Pharmaceutical